Several factors influence BC prognosis, including patient demographics (e.g., age) (3, 4), tumor characteristics (e.g., size and lymph node involvement) (5), and tumor-derived biomarkers (e.g., hormone receptor status) (6, 7). Here, NR4A1 is linked to neoplasm.